bluebird bio, Inc. (0HOH.L)

USD 8.02

(1.01%)

Eps Summary of bluebird bio, Inc.

  • bluebird bio, Inc.'s latest annual eps in 2023 was -1.93 USD , up 43.07% from previous year.
  • bluebird bio, Inc.'s latest quarterly eps in 2024 Q2 was -0.42 USD , down -16.67% from previous quarter.
  • bluebird bio, Inc. reported an annual eps of -3.39 USD in 2022, up 58.46% from previous year.
  • bluebird bio, Inc. reported an annual eps of -8.16 USD in 2021, up 17.99% from previous year.
  • bluebird bio, Inc. reported a quarterly eps of -0.42 USD for 2024 Q2, down -16.67% from previous quarter.
  • bluebird bio, Inc. reported a quarterly eps of -0.66 USD for 2023 Q3, up 1.49% from previous quarter.

Annual Eps Chart of bluebird bio, Inc. (2023 - 2011)

Historical Annual Eps of bluebird bio, Inc. (2023 - 2011)

Year Eps Eps Growth
2023 -1.93 USD 43.07%
2022 -3.39 USD 58.46%
2021 -8.16 USD 17.99%
2020 -9.95 USD 30.47%
2019 -14.31 USD -33.99%
2018 -10.68 USD -38.52%
2017 -7.71 USD -9.05%
2016 -7.07 USD -46.99%
2015 -4.81 USD -162.84%
2014 -1.83 USD 9.41%
2013 -2.02 USD -94.23%
2012 -1.04 USD -52.94%
2011 -0.68 USD 0.0%

Peer Eps Comparison of bluebird bio, Inc.

Name Eps Eps Difference
Thermo Fisher Scientific Inc. 15.53 USD 112.428%
Agios Pharmaceuticals, Inc. -6.33 USD 69.51%
Atara Biotherapeutics, Inc. -65.18 USD 97.039%
Cara Therapeutics, Inc. -2.19 USD 11.872%
uniQure N.V. -6.47 USD 70.17%
Amicus Therapeutics, Inc. -0.51 USD -278.431%
Imunon, Inc. -2.16 USD 10.648%
Dynavax Technologies Corporation -0.05 USD -3791.129%
Editas Medicine, Inc. -2.02 USD 4.455%
Illumina, Inc. -7.35 USD 73.741%
Iovance Biotherapeutics, Inc. -1.89 USD -2.116%
IQVIA Holdings Inc. 7.39 USD 126.116%
Mettler-Toledo International Inc. 36.10 USD 105.346%
Myriad Genetics, Inc. -1.39 USD -38.849%
Neurocrine Biosciences, Inc. 2.56 USD 175.391%
Sarepta Therapeutics, Inc. -5.80 USD 66.724%
Supernus Pharmaceuticals, Inc. 0.02 USD 8108.299%
Verastem, Inc. -3.96 USD 51.263%
Walgreens Boots Alliance, Inc. -10.01 USD 80.719%
Waters Corporation 10.87 USD 117.755%
Biogen Inc. 8.02 USD 124.065%
Nektar Therapeutics -1.45 USD -33.103%
Perrigo Company plc -0.09 USD -1955.378%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 81.28%
Heron Therapeutics, Inc. -0.80 USD -141.25%
Unity Biotechnology, Inc. -2.70 USD 28.519%
BioMarin Pharmaceutical Inc. 0.89 USD 316.854%
Sangamo Therapeutics, Inc. -1.48 USD -30.405%
Evolus, Inc. -1.08 USD -78.704%
Adicet Bio, Inc. -3.31 USD 41.692%
Aclaris Therapeutics, Inc. -1.27 USD -51.969%
Regeneron Pharmaceuticals, Inc. 37.05 USD 105.209%
Esperion Therapeutics, Inc. -2.03 USD 4.926%
FibroGen, Inc. -2.92 USD 33.904%
Agilent Technologies, Inc. 4.22 USD 145.735%
OPKO Health, Inc. -0.25 USD -672.0%
Homology Medicines, Inc. -7.41 USD 73.954%
Geron Corporation -0.32 USD -503.125%
Alnylam Pharmaceuticals, Inc. -3.52 USD 45.17%
Exelixis, Inc. 0.65 USD 396.923%
Viking Therapeutics, Inc. -0.91 USD -112.088%
Anavex Life Sciences Corp. -0.60 USD -221.667%
Intellia Therapeutics, Inc. -5.42 USD 64.391%
Zoetis Inc. 5.08 USD 137.992%
Axsome Therapeutics, Inc. -5.27 USD 63.378%
Abeona Therapeutics Inc. -2.53 USD 23.715%
Vertex Pharmaceuticals Incorporated 14.05 USD 113.737%
Kala Pharmaceuticals, Inc. -17.35 USD 88.876%
Ionis Pharmaceuticals, Inc. -2.56 USD 24.609%
Corcept Therapeutics Incorporated 1.02 USD 289.216%
Halozyme Therapeutics, Inc. 2.13 USD 190.61%
Blueprint Medicines Corporation -8.37 USD 76.941%
Insmed Incorporated -5.34 USD 63.858%
TG Therapeutics, Inc. 0.09 USD 2261.254%
Incyte Corporation 2.67 USD 172.285%
Emergent BioSolutions Inc. -14.85 USD 87.003%